Memantine for the Long Term Management of Neuropsychiatric Symptoms in Alzheimer's disease - MAIN-AD

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-004897-26

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this trial is to evaluate the efficacy of 24 weeks treatment with memantine in comparison to neuroleptics in patients with Alzheimer's disease for the maintainenance of self care.


Critère d'inclusion

  • Alzheimer's disease

Liens